LP417568-5
CYP2C9 gene allele
Active
Description
Cytochrome P450-2C9 (CYP2C9; [HGNC Gene ID: 2623]), a member of the cytochrome P450 mixed-function oxidase system, is involved in the metabolism 10-15% of drugs in current clinical use. Genetic variations in CYP2C9 can affect the response (i.e., efficacy or toxicity) to drugs metabolized by CYP2C9 and selection of alternative dosing or agents may be necessary in individuals with specific CYP2C9 genetic variations. PMID: 25099164 PMID: 21900891 See https://www.pharmgkb.org/gene/PA126 for more information and dosing guidelines for drugs impacted by CYP2C9 genetic variation. Source: Clinical Pharmacogenetics Implementation Consortium
Basic Part Properties
- Part Display Name
- CYP2C9 gene allele
- Part Type
- Component (Describes the core component or analyte measured)
- Created On
- 2020-01-30
- Construct for LOINC Short Name
- CYP2C9 allele
LOINC Terminology Service (API) using HL7® FHIR® Get Info
Requests to this service require a free LOINC username and password. Below is a sample of the possible capabilities. See the LOINC Terminology Service documentation for more information.
- CodeSystem lookup
- https:
//fhir.loinc.org/CodeSystem/$lookup?system=http: //loinc.org&code=LP417568-5 - ConceptMap translate
- https:
//fhir.loinc.org/ConceptMap/$translate?system=http: //loinc.org&code=LP417568-5
Language Variants Get Info
Tag | Language | Translation |
---|---|---|
zh-CN | Chinese (China) | CYP2C9 基因等位基因 |
nl-NL | Dutch (Netherlands) | CYP2C9-allel |
it-IT | Italian (Italy) | CYP2C9, gene allele |
es-ES | Spanish (Spain) | Alelo del gen CYP2C9 |
LOINC Copyright
Copyright © 2024 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright